Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Limonene analogue XR-3054 is a novel protein farnesyltransferase inhibitor

Aug. 11, 1999

PD-184352 inhibits growth of colon tumors in mice via interference with MAPK pathway

Aug. 11, 1999

Licensing opportunity from NIH: NAT modulators for enhancing efficacy, reducing toxicity of drugs

Aug. 11, 1999

Idec and NCI form partnership to broaden use of ibritumomab tiuxetan

Aug. 10, 1999

Licensing opportunity from NIH: improved technology for radiotherapy of cancer and other diseases

Aug. 10, 1999

Korean researchers synthesize anticancer platinum complexes

Aug. 10, 1999

NCI scientists initiate testing of thalidomide in colorectal cancer patients

Aug. 10, 1999

SCRAS team evaluates topoisomerase inhibitors for cancer indications

Aug. 10, 1999

Phase Ia results reported for Cell Pathways' novel SAAND

Aug. 10, 1999

Takeda scientists synthesize and evaluate GnRH antagonists

Aug. 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...